Gennex Laboratories has informed that in pursuance of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading window for dealing in the securities of the Company shall remain closed from July 01, 2023 till 48 hours after the public announcement through Board of Directors in their Meeting held for announcing the Unaudited Financial Results for the Quarter ended June 30, 2023 along with other matters for which trading window is required to be closed. The Board Meeting date to approve the Unaudited Financial Results of the Company for the Quarter ending on June 30, 2023 will be informed in due course. All Promoters / designated / concerned persons are advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.
The above information is a part of company’s filings submitted to BSE.